497 related articles for article (PubMed ID: 18167263)
1. [Neurofilament protein light in multiple sclerosis].
Zhang Y; Li X; Qiao J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
3. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against light neurofilaments in multiple sclerosis patients.
Bartos A; Fialová L; Soukupová J; Kukal J; Malbohan I; Pitha J
Acta Neurol Scand; 2007 Aug; 116(2):100-7. PubMed ID: 17661795
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
[TBL] [Abstract][Full Text] [Related]
7. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
Bartosik-Psujek H; Archelos JJ
J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285
[TBL] [Abstract][Full Text] [Related]
8. High CSF neurofilament heavy chain levels in neuromyelitis optica.
Miyazawa I; Nakashima I; Petzold A; Fujihara K; Sato S; Itoyama Y
Neurology; 2007 Mar; 68(11):865-7. PubMed ID: 17353477
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of myelin basic protein levels with receiver operating characteristic curves for diagnosis of multiple sclerosis].
Tian ZJ; Zhao XX; Li ZH; Zhang F; Cao FT; Li SM; Shao M; Dong YX
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):250-2. PubMed ID: 19246291
[TBL] [Abstract][Full Text] [Related]
10. Exposure to methylmercury results in serum autoantibodies to neurotypic and gliotypic proteins.
el-Fawal HA; Gong Z; Little AR; Evans HL
Neurotoxicology; 1996; 17(2):531-9. PubMed ID: 8856747
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis.
Warren KG; Catz I
Ann Neurol; 1986 Jul; 20(1):20-5. PubMed ID: 2427010
[TBL] [Abstract][Full Text] [Related]
12. Exposure to methyl mercury results in serum autoantibodies to neurotypic and gliotypic proteins.
el-Fawal HA; Gong Z; Little AR; Evans HL
Neurotoxicology; 1996; 17(1):267-76. PubMed ID: 8784838
[TBL] [Abstract][Full Text] [Related]
13. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
15. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
[TBL] [Abstract][Full Text] [Related]
17. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
Warren KG; Catz I; Johnson E; Mielke B
Ann Neurol; 1994 Mar; 35(3):280-9. PubMed ID: 7510098
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica].
Yang Y; Huang DH; Wu L; Wu WP
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):606-9. PubMed ID: 20450783
[TBL] [Abstract][Full Text] [Related]
19. Neurofilament light as a prognostic marker in multiple sclerosis.
Salzer J; Svenningsson A; Sundström P
Mult Scler; 2010 Mar; 16(3):287-92. PubMed ID: 20086018
[TBL] [Abstract][Full Text] [Related]
20. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]